BIO.B
Bio-Rad Laboratories B·NYSE
--
--(--)
--
--(--)
6.57 / 10
Outperform
Liquidity flow evaluation is positive (6.57/10), showing robust fund inflows with Small, Medium, and Large patterns indicating net inflow activity. However, the overall fund-flow trend is labeled negative, hinting at possible reversals. There are no analyst ratings available (ana_eval = -1), so the sentiment is primarily derived from fund-flow data, pointing to optimism but with caveats.
Fund Flow Rating
What is the market sentiment for BIO.B?
- BIO.B holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.57/10 (Outperform).
